INSULET CORP 4
4 · INSULET CORP · Filed Sep 4, 2014
Insider Transaction Report
Form 4
INSULET CORPPODD
DeSisto Duane
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2014-09-02$15.16/sh+20,000$303,200→ 277,184 total - Sale
Common Stock
2014-09-02$36.30/sh−20,000$725,998→ 257,184 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2014-09-02−20,000→ 10,000 totalExercise: $15.16Exp: 2020-03-01→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]Includes 35,000 restricted stock units granted on April 1, 2012, which vest one-half of the total units on April 1, 2015 and one-half of the total units on April 1, 2016; 45,000 restricted stock units granted on March 1, 2013, which vest one-third of the total units on March 1, 2015, one-third of the total units on March 1, 2016 and one-third of the total units on March 1, 2017; 40,000 performance share units granted on March 1, 2013, which vest one-half of the total units on March 1, 2015 and one-half of the total units on March 1, 2016; and 44,000 restricted stock units granted on March 3, 2014, which vest one-third of the total units on March 3, 2015, one-third of the total units on March 3, 2016 and one-third of the total units on March 3, 2017. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
- [F2]Includes an aggregate of 9,494 shares acquired under the Insulet Corporation Amended and Restated 2007 Employee Stock Purchase Plan on the following dates: 219 shares acquired on December 31, 2007; 694 shares acquired on June 30, 2008; 1,429 shares acquired on December 31, 2008; 1,431 shares acquired on June 30, 2009; 772 shares acquired on December 31, 2009; 749 shares acquired on June 30, 2010; 732 shares acquired on December 31, 2010; 532 shares acquired on June 30, 2011; 640 shares acquired on December 30, 2011; 580 shares acquired on June 29, 2012; 589 shares acquired on December 31, 2012; 410 shares acquired on June 28, 2013; 360 shares acquired on December 31, 2013; and 357 shares acquired on June 30, 2014.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2014.
- [F4]The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $36.02 to $36.51. The reporting Person hereby undertakes, upon request of the Staff of the U.S Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- [F5]This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.